Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 1/20 | 0.41 |
| ▸ | NPY4R | P50391 | 6/20 | 0.39 |
| ▸ | NPY1R | P25929 | 5/20 | 0.39 |
| ▸ | NPY2R | P49146 | 4/20 | 0.39 |
| ▸ | NPY5R | Q15761 | 4/20 | 0.39 |
| ▸ | KISS1R | Q969F8 | 2/20 | 0.39 |
| ▸ | VIPR1 | P32241 | 1/20 | 0.37 |
| ▸ | TLR2 | O60603 | 1/20 | 0.37 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10335931 | 0.89 | VIPR1 (0.46) | BACE1KISS1RVIPR1TLR2RXFP1 | |
| SCHEMBL30553767 | 0.86 | ENPEP (0.44) | NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL29901551 | 0.86 | NPY4R (0.52) | NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL27766371 | 0.85 | ENPEP (0.43) | — | |
| SCHEMBL27745761 | 0.85 | ENPEP (0.45) | NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL29540150 | 0.85 | FNTA (0.44) | NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL29985357 | 0.85 | FNTA (0.44) | NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL29816322 | 0.84 | NPY4R (0.46) | NPY4RNPY1RNPY2RNPY5RKISS1R | |
| SCHEMBL29805487 | 0.84 | BACE1 (0.44) | BACE1NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL38663446 | 0.84 | BACE1 (0.51) | BACE1NPY4RNPY1RNPY2RNPY5R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250313651-A1 | ANTIBODIES THAT BIND IL-4 AND/OR IL-13 AND THEIR USES | SANOFI (FR) | 2025-10-09 | — | — | US | disclosed |
| CN-113480647-B | Antibodies that bind to IL-4 and/or IL-13 and uses thereof | 塞诺菲-安万特股份有限公司 | 2025-03-28 | — | — | CN | disclosed |
| CN-111909273-B | humanized anti-CXCR 5 antibodies, derivatives thereof and uses thereof | 塞诺菲-安万特股份有限公司 | 2024-03-26 | — | — | CN | disclosed |
| US-20230235088-A1 | ANTIBODIES THAT BIND IL-4 AND/OR IL-13 AND THEIR USES | SANOFI (FR) | 2023-07-27 | — | — | US | disclosed |
| US-11453727-B2 | Antibodies that bind IL-4 and/or IL-13 and their uses | SANOFI (FR) | 2022-09-27 | — | — | US | disclosed |
| US-20220073629-A1 | Humanized Anti-CXCR5 Antibodies, Derivatives Thereof and Their Uses | SANOFI (FR) | 2022-03-10 | — | — | US | disclosed |